(Q42991678)

12 November 2017

title

Therapeutic effects of pegylated interferon plus ribavirin in chronic hepatitis C patients with occult hepatitis B virus dual infection (English)

1 reference

12 November 2017

1 reference

1 reference

1 reference

1 reference

Li-Wei Chen

1

1 reference

12 November 2017

Rong-Nan Chien

2

1 reference

12 November 2017

Cho-Li Yen

3

1 reference

12 November 2017

Jia-Jang Chang

4

1 reference

12 November 2017

Ching-Jung Liu

5

1 reference

12 November 2017

Chih-Lang Lin

6

1 reference

12 November 2017

publication date

9 October 2009

1 reference

Journal of Gastroenterology and Hepatology

12 November 2017

published in

1 reference

12 November 2017

volume

25

1 reference

12 November 2017

issue

2

1 reference

12 November 2017

page(s)

259-263

1 reference

Isolated antibody to hepatitis B core antigen in patients with chronic hepatitis C virus infection

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2009.06006.X

Role of hepatitis C and delta viruses in the termination of chronic hepatitis B surface antigen carrier state: a multivariate analysis in a longitudinal follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2009.06006.X

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2009.06006.X

Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2009.06006.X

10.1111/J.1440-1746.2009.06006.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference